88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

UndoAge and Novonesis Forge Strategic Partnership to Drive High-Quality Development of China's Probiotic Industry Beijing , June 10, 2026 /PRNewswire/ -- UndoAge and Novonesis, a global biosolutions company backed by Novo Holdings, signed a Memorandum of Understanding (MOU) in Beijing on June 9 . The partnership ... 2026-06-10T Biotechnology Health Care/Hospital
Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders Partnership will combine n-Lorem's cutting-edge antisense oligonucleotide (ASO) technology and Servier's R&D expertise with the aim of advancing ASO technology and delivering precision medicine ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , June 10, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target BOSTON and SHENZHEN, China , June 10, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading platform in artificial intelligence (AI) and robotics-driven drug discovery, today announced a strategic partnership ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China SHANGHAI and HONG KONG , June 10, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor HANGZHOU, China, SHANGHAI and BOSTON , June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
PromptBio Launched All-New Agentic AI Platform For Life Sciences, Turning Scientific Intent Into Executable Experiments The PromptBio Platform combines conversational AI with multi-agent orchestration to accelerate discovery from hypotheses to insights ... 2026-06-09T Biotechnology Computer Software Computer/Electronics Medical/Pharmaceuticals
Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378 COPD study initiation expands SKB378/WIN378 development into a second major respiratory disease SKB378/WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase ... 2026-06-09T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with the RIGHT Foundation to drive process development that enhances ... 2026-06-09T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whole-cell design eliminates cell teardown, reducing ... 2026-06-09T Biotechnology Computer/Electronics Health Care/Hospital Medical Equipment

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved